Literature DB >> 30191480

The mitochondrial Nod-like receptor NLRX1 modifies apoptosis through SARM1.

Samuel A Killackey1, Muhammed A Rahman2, Fraser Soares1, Ashley B Zhang1, Mena Abdel-Nour1, Dana J Philpott2, Stephen E Girardin3,4.   

Abstract

NLRX1, the mitochondrial NOD-like receptor (NLR), modulates apoptosis in response to both intrinsic and extrinsic cues. Insights into the mechanism of how NLRX1 influences apoptosis remain to be determined. Here, we demonstrate that NLRX1 associates with SARM1, a protein with a toll/interleukin-1 receptor (TIR)-containing domain also found in adaptor proteins downstream of toll-like receptors, such as MyD88. While a direct role of SARM1 in innate immunity is unclear, the protein plays essential roles in Wallerian degeneration (WD), a type of neuronal catabolism occurring following axonal severing or damage. In non-neuronal cells, we found that endogenous SARM1 was equally distributed in the cytosol and the mitochondrial matrix, where association with NLRX1 occurred. In these cells, the apoptotic role of NLRX1 was fully dependent on SARM1, indicating that SARM1 was downstream of NLRX1 in apoptosis regulation. In primary murine neurons, however, Wallerian degeneration induced by vinblastine or NGF deprivation occurred in SARM1- yet NLRX1-independent manner, suggesting that WD requires the cytosolic pool of SARM1 or that NLRX1 levels in neurons are too low to contribute to WD regulation. Together, these results shed new light into the mechanisms through which NLRX1 controls apoptosis and provides evidence of a new link between NLR and TIR-containing proteins.

Entities:  

Keywords:  Apoptosis; Mitochondria; NLRX1; Nod-like receptors; SARM1

Mesh:

Substances:

Year:  2018        PMID: 30191480     DOI: 10.1007/s11010-018-3444-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  15 in total

Review 1.  Recent Developments of Novel Pharmacologic Therapeutics for Prevention of Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Shuiying Hu; Kevin M Huang; Elizabeth J Adams; Charles L Loprinzi; Maryam B Lustberg
Journal:  Clin Cancer Res       Date:  2019-05-23       Impact factor: 12.531

Review 2.  SARM1 can be a potential therapeutic target for spinal cord injury.

Authors:  Qicheng Lu; Benson O A Botchway; Yong Zhang; Tian Jin; Xuehong Liu
Journal:  Cell Mol Life Sci       Date:  2022-02-28       Impact factor: 9.261

3.  Mitochondrial Localization of SARM1 in Acrylamide Intoxication Induces Mitophagy and Limits Neuropathy.

Authors:  Shuai Wang; Mingxue Song; Hui Yong; Cuiqin Zhang; Kang Kang; Zhidan Liu; Yiyu Yang; Zhengcheng Huang; Shu'e Wang; Haotong Ge; Xiulan Zhao; Fuyong Song
Journal:  Mol Neurobiol       Date:  2022-09-29       Impact factor: 5.682

Review 4.  NLR in eXile: Emerging roles of NLRX1 in immunity and human disease.

Authors:  Robert J Pickering; Lee M Booty
Journal:  Immunology       Date:  2020-12-28       Impact factor: 7.397

5.  Short prokaryotic Argonaute systems trigger cell death upon detection of invading DNA.

Authors:  Balwina Koopal; Ana Potocnik; Sumanth K Mutte; Cristian Aparicio-Maldonado; Simon Lindhoud; Jacques J M Vervoort; Stan J J Brouns; Daan C Swarts
Journal:  Cell       Date:  2022-04-04       Impact factor: 66.850

Review 6.  NLRX1 Is a Multifaceted and Enigmatic Regulator of Immune System Function.

Authors:  Margaret A Nagai-Singer; Holly A Morrison; Irving C Allen
Journal:  Front Immunol       Date:  2019-10-11       Impact factor: 7.561

Review 7.  Programmed axon degeneration: from mouse to mechanism to medicine.

Authors:  Michael P Coleman; Ahmet Höke
Journal:  Nat Rev Neurosci       Date:  2020-03-09       Impact factor: 34.870

8.  NLRX1 Enhances Glutamate Uptake and Inhibits Glutamate Release by Astrocytes.

Authors:  Shaimaa Mahmoud; Marjan Gharagozloo; Camille Simard; Abdelaziz Amrani; Denis Gris
Journal:  Cells       Date:  2019-04-30       Impact factor: 6.600

9.  NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunity.

Authors:  Marjan Gharagozloo; Shaimaa Mahmoud; Camille Simard; Kenzo Yamamoto; Diwakar Bobbala; Subburaj Ilangumaran; Matthew D Smith; Albert Lamontagne; Samir Jarjoura; Jean-Bernard Denault; Véronique Blais; Louis Gendron; Carles Vilariño-Güell; A Dessa Sadovnick; Jenny P Ting; Peter A Calabresi; Abdelaziz Amrani; Denis Gris
Journal:  PLoS Biol       Date:  2019-09-16       Impact factor: 8.029

10.  MiR-423-5p Regulates Cells Apoptosis and Extracellular Matrix Degradation via Nucleotide-Binding, Leucine-Rich Repeat Containing X1 (NLRX1) in Interleukin 1 beta (IL-1β)-Induced Human Nucleus Pulposus Cells.

Authors:  Hanrong Xu; Liefeng Ji; Chunhua Yu; Qiming Chen; Qiangqiang Ge; Yinjiang Lu
Journal:  Med Sci Monit       Date:  2020-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.